Skip to main content

Advertisement

Table 1 CD24 and CD44 expressions in gastric carcinomas according to clinicopathological parameters

From: CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach

  CD24 positive rate n (%) P value CD44 positive rate n (%) P value
Gender     
  Male (n=221) 92(41.6) 0.148 133(60.2) 0.835
  Female (n=69) 22(31.9)   45(65.2)  
Age(y)     
  ≤60 (n=127) 48(37.8) 0.435 85(66.9) 0.087
  >60 (n=163) 69(42.3)   93(57.0)  
H.pylori infection (n=103)     
  Positive (n=67) 24(35.8) 0.096 48(71.6) 0.815
  Negative (n=36) 19(52.8)   25(69.4)  
Lauren classification     
  Intestinal type (n=104) 42(40.3) 0.965 67(64.4) 0.168
  Diffuse type (n=186) 77(41.3)   103(55.3)  
WHO classification     
  Papillary adenocarcinoma (n=4) 1(25.0) 0.906 4(100.0) 0.064
  Tubular adenocarcinoma     
   Well (n=1) 0(0.0)   0(0.0)  
   Moderate (n=98) 30(30.6)   49(50.0)  
   Poor (n=153) 47(30.7)   87(56.9)  
Mucinous adenocarcinoma (n=27) 7(25.9)   13(48.1)  
Poorly cohesive carcinomas (Signet ring cell carcinomas) (n=7) 1(14.3)   1(14.3)  
Lymph-vascular invasion     
  Absent (n=134) 56(41.8) 0.642 72(53.7) 0.013
  Present (n=156) 61(39.1)   106(67.9)  
TNM stage     
  I (n=23) 10(43.5) 0.844 16(69.6) 0.559
  II (n=47) 19(40.4)   32(68.1)  
  III (n=187) 77(41.2)   110(58.9)  
  IV (n=33) 11(33.3)   20(60.6)  
Invasion     
  T1 (n=9) 2(22.2) 0.537 7(77.8) 0.485
  T2 (n=36) 14(38.9)   22(61.1)  
  T3 (n=212) 85(40.1)   132(62.2)  
  T4 (n=33) 16(48.5)   17(51.5)  
Lymph node metastasis     
  N0 (n=62) 27(43.5) 0.445 40(64.5) 0.534
  N1 (n=89) 39(43.8)   49(55.1)  
  N2 (n=74) 24(32.4)   47(63.5)  
  N3 (n=65) 27(41.5)   42(64.6)  
Survival     
  Survived (n=171) 62(36.3) 0.089 96(56.1) 0.028
  Died (n=119) 55(46.2)   82(68.9)